Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Menopause affects hair and skin; more research needed for treatment.

The experiment showed that human skin grown in the lab started to form early hair structures when special cell clusters were added.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Cell-based therapies show promise for treating Limbal Stem Cell Deficiency but need more research.

Scientists have made progress in creating replacement teeth, hair, and glands that work, which could lead to new treatments for missing teeth, baldness, and dryness conditions.

Fungal infections in lab animals can interfere with research.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Scalp hair grows at 0.37 mm/day, forearm hair at 0.18 mm/day, and thigh hair at 0.30 mm/day, with no significant differences found in people with certain hair conditions.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

Diabetes often causes various skin problems and complications.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Minoxidil in breast milk may harm nursing infants.

A specific gene change plus an additional mutation in the same gene cause hereditary trichilemmal cysts.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.